Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brainsway
MedTech
BrainsWay study tests sped-up neurostim regimen for depression
Shortcuts aren’t common in medicine, but BrainsWay may have found an effective one for treating major depressive disorder.
Andrea Park
Oct 18, 2023 1:20pm
FDA OKs BrainsWay's 2nd neurostimulation coil for depression
Aug 30, 2022 10:30am
FDA OKs BrainsWay’s neurostim device to ease anxious depression
Aug 18, 2021 9:49am
BrainsWay shows early success treating ADHD with strong magnets
Feb 20, 2020 10:21am
Magnetic therapy developer Brainsway files for $30M Nasdaq IPO
Jan 15, 2019 5:54pm
FDA clears first magnetic, noninvasive device treatment for OCD
Aug 20, 2018 9:27am
